Lista de obras -

A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detection

article

Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy

artículo científico publicado en 2019

Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China.

artículo científico publicado en 2013

Comparative evaluation of a novel TaqMan real-time reverse transcription–polymerase chain reaction assay for hepatitis A virus detection ⬇️

artículo científico publicado el 7 de marzo de 2013

Complete genome analysis of hepatitis B virus in Qinghai-Tibet plateau: the geographical distribution, genetic diversity, and co-existence of HBsAg and anti-HBs antibodies

artículo científico publicado en 2020

Complete genome sequences of the SARS-CoV: the BJ Group (Isolates BJ01-BJ04).

artículo científico publicado en 2003

Construction and Immunological Evaluation of CpG-Au@HBc Virus-Like Nanoparticles as a Potential Vaccine

artículo científico publicado en 2016

Design of Fusion Proteins for Efficient and Soluble Production of Immunogenic Ebola Virus Glycoprotein in Escherichia coli.

artículo científico publicado en 2018

Development of a sandwich ELISA for the quantification of enterovirus 71.

artículo científico publicado en 2013

Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities ⬇️

artículo científico publicado el 30 de marzo de 2011

Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China

article

Efficient Humoral and Cellular Immune Responses Induced by a Chimeric Virus-like Particle Displaying the Epitope of EV71 without Adjuvant

article

Efficient encapsulation of Fe₃O₄ nanoparticles into genetically engineered hepatitis B core virus-like particles through a specific interaction for potential bioapplications.

artículo científico publicado en 2014

Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.

artículo científico publicado en 2008

Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin

artículo científico publicado en 2015

Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme ⬇️

artículo científico publicado el 15 de diciembre de 2010

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

artículo científico publicado en 2009

Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006

artículo científico publicado en 2014

Epitope-based recombinant diagnostic antigen to distinguish natural infection from vaccination with hepatitis A virus vaccines.

artículo científico publicado en 2016

Evolution and genetic characterization of hepatitis A virus isolates in China

artículo científico publicado en 2015

Expression and Purification of Recombinant Hepatitis Delta Virus (HDV) Antigen for Use in a Diagnostic ELISA for HDV Infection Using the High-Density Fermentation Strategy in Escherichia coli.

artículo científico publicado en 2016

Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides

scientific article published on 30 September 2009

Genetic diversity of hepatitis A virus in China: VP3-VP1-2A genes and evidence of quasispecies distribution in the isolates

artículo científico publicado en 2013

Hemagglutinin and neuraminidase matching patterns of two influenza A virus strains related to the 1918 and 2009 global pandemics.

artículo científico publicado en 2009

Hepatitis A outbreaks in China during 2006: application of molecular epidemiology.

scientific article published on 19 December 2008

Hepatitis B Immunoprophylactic Failure and Characteristics of the Hepatitis B Virus Gene in Mother-Infant Pairs in Parts of China.

artículo científico publicado en 2016

Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto- and transmembrane domains.

artículo científico publicado en 2009

Hepatitis C virus-specific cellular and humoral immune responses following immunization with a multi-epitope fusion protein ⬇️

artículo científico publicado el 28 de septiembre de 2011

Hepatitis E outbreak in a mechanical factory in Qingdao City, China

scientific article published on 13 July 2019

High expression of small hepatitis D antigen in Escherichia coli and ELISA for diagnosis of hepatitis D virus.

artículo científico publicado en 2013

Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination

scientific article published on 30 May 2019

Immune responses to HBsAg conjugated to protein D of non-typeable Haemophilus influenzae in mice

artículo científico publicado en 2015

Improved Stable Indocyanine Green (ICG)-Mediated Cancer Optotheranostics with Naturalized Hepatitis B Core Particles.

artículo científico publicado en 2018

Intranasal Immunization Using CTA1-DD as a Mucosal Adjuvant for an Inactivated Influenza Vaccine

scientific article published on 01 July 2019

Intranasal inoculate of influenza virus vaccine against lethal virus challenge

artículo científico publicado en 2018

Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge

scientific article published on 06 September 2018

Investigation of the risk factors associated with the failure of hepatitis B vaccination of neonates in Yunnan province, China

article

Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?

artículo científico publicado en 2017

Long-term efficacy of 10–12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities ⬇️

artículo científico publicado el 30 de enero de 2012

Long-term protection at 20-31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community

scientific article published on 29 August 2019

Modularized Peptides Modified HBc Virus-Like Particles for Encapsulation and Tumor-Targeted Delivery of Doxorubicin.

artículo científico publicado en 2017

Molecular epidemiological study of hepatitis B virus genotypes in Southwest, China.

artículo científico publicado en 2014

Multiplex hydrolysis probe real-time PCR for simultaneous detection of hepatitis A virus and hepatitis E virus

artículo científico publicado en 2014

Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.

artículo científico publicado en 2009

Prevalence and risk factors of hepatitis C among former blood donors in rural China.

artículo científico publicado en 2012

Prevalence of human parvovirus B19, bocavirus, and PARV4 in blood samples from the general population of China and lack of a correlation between parvovirus and hepatitis B co-infection

artículo científico publicado en 2013

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

artículo científico publicado en 2017

Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.

artículo científico publicado en 2015

Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccination.

artículo científico

Risk factors of hepatitis C virus transmission and genotype distribution in former blood donors from Chinese rural area

artículo científico publicado en 2015

The E protein is a multifunctional membrane protein of SARS-CoV.

scientific article published on May 2003

The long-term efficacy of Chinese hamster ovary cell derived hepatitis B vaccine after being used for 14-16 years in Chinese rural communities

artículo científico publicado en 2014

The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China.

artículo científico publicado en 2015

The structural characterization and antigenicity of the S protein of SARS-CoV.

artículo científico publicado en 2003

The structure analysis and antigenicity study of the N protein of SARS-CoV.

artículo científico publicado en 2003

Theranostic Quercetin Nanoparticle for Treatment of Hepatic Fibrosis

artículo científico publicado en 2019

Whole-gene analysis of two groups of hepatitis B virus C/D inter-genotype recombinant strains isolated in Tibet, China

artículo científico publicado en 2017

Lista de obras de

A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detection

Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy

Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China.

Comparative evaluation of a novel TaqMan real-time reverse transcription–polymerase chain reaction assay for hepatitis A virus detection ⬇️

Complete genome analysis of hepatitis B virus in Qinghai-Tibet plateau: the geographical distribution, genetic diversity, and co-existence of HBsAg and anti-HBs antibodies

Complete genome sequences of the SARS-CoV: the BJ Group (Isolates BJ01-BJ04).

Construction and Immunological Evaluation of CpG-Au@HBc Virus-Like Nanoparticles as a Potential Vaccine

Design of Fusion Proteins for Efficient and Soluble Production of Immunogenic Ebola Virus Glycoprotein in Escherichia coli.

Development of a sandwich ELISA for the quantification of enterovirus 71.

Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities ⬇️

Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China

Efficient Humoral and Cellular Immune Responses Induced by a Chimeric Virus-like Particle Displaying the Epitope of EV71 without Adjuvant

Efficient encapsulation of Fe₃O₄ nanoparticles into genetically engineered hepatitis B core virus-like particles through a specific interaction for potential bioapplications.

Efficient neutralizing activity of cocktailed recombinant human antibodies against hepatitis A virus infection in vitro and in vivo.

Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin

Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme ⬇️

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006

Epitope-based recombinant diagnostic antigen to distinguish natural infection from vaccination with hepatitis A virus vaccines.

Evolution and genetic characterization of hepatitis A virus isolates in China

Expression and Purification of Recombinant Hepatitis Delta Virus (HDV) Antigen for Use in a Diagnostic ELISA for HDV Infection Using the High-Density Fermentation Strategy in Escherichia coli.

Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides

Genetic diversity of hepatitis A virus in China: VP3-VP1-2A genes and evidence of quasispecies distribution in the isolates

Hemagglutinin and neuraminidase matching patterns of two influenza A virus strains related to the 1918 and 2009 global pandemics.

Hepatitis A outbreaks in China during 2006: application of molecular epidemiology.

Hepatitis B Immunoprophylactic Failure and Characteristics of the Hepatitis B Virus Gene in Mother-Infant Pairs in Parts of China.

Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto- and transmembrane domains.

Hepatitis C virus-specific cellular and humoral immune responses following immunization with a multi-epitope fusion protein ⬇️

Hepatitis E outbreak in a mechanical factory in Qingdao City, China

High expression of small hepatitis D antigen in Escherichia coli and ELISA for diagnosis of hepatitis D virus.

Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination

Immune responses to HBsAg conjugated to protein D of non-typeable Haemophilus influenzae in mice

Improved Stable Indocyanine Green (ICG)-Mediated Cancer Optotheranostics with Naturalized Hepatitis B Core Particles.

Intranasal Immunization Using CTA1-DD as a Mucosal Adjuvant for an Inactivated Influenza Vaccine

Intranasal inoculate of influenza virus vaccine against lethal virus challenge

Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge

Investigation of the risk factors associated with the failure of hepatitis B vaccination of neonates in Yunnan province, China

Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?

Long-term efficacy of 10–12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities ⬇️

Long-term protection at 20-31 years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community

Modularized Peptides Modified HBc Virus-Like Particles for Encapsulation and Tumor-Targeted Delivery of Doxorubicin.

Molecular epidemiological study of hepatitis B virus genotypes in Southwest, China.

Multiplex hydrolysis probe real-time PCR for simultaneous detection of hepatitis A virus and hepatitis E virus

Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.

Prevalence and risk factors of hepatitis C among former blood donors in rural China.

Prevalence of human parvovirus B19, bocavirus, and PARV4 in blood samples from the general population of China and lack of a correlation between parvovirus and hepatitis B co-infection

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.

Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccination.

Risk factors of hepatitis C virus transmission and genotype distribution in former blood donors from Chinese rural area

The E protein is a multifunctional membrane protein of SARS-CoV.

The long-term efficacy of Chinese hamster ovary cell derived hepatitis B vaccine after being used for 14-16 years in Chinese rural communities

The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China.

The structural characterization and antigenicity of the S protein of SARS-CoV.

The structure analysis and antigenicity study of the N protein of SARS-CoV.

Theranostic Quercetin Nanoparticle for Treatment of Hepatic Fibrosis

Whole-gene analysis of two groups of hepatitis B virus C/D inter-genotype recombinant strains isolated in Tibet, China